Successful treatment of cardiac sarcoidosis with infliximab

Journal of Rheumatology

Volumn 35, Issue 8, 2008, Pages 1686-1688

  Barnabe, Cheryl ^a   McMeekin, James ^a   Howarth, Andrew ^a   Martin, Liam ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; PREDNISONE;

ADULT; ATRIOVENTRICULAR BLOCK; CASE REPORT; EXTENSOR MUSCLE; FEMALE; HEART DISEASE; HEART SARCOIDOSIS; HUMAN; LETTER; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SARCOIDOSIS; TACHYCARDIA; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; CARDIOMYOPATHIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SARCOIDOSIS;

EID: 49049089329     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Mori M, Hanon S, Rachko M. Cardiac sarcoidosis presenting with ventricular arrhythmias: Case report and review of the literature. Int J Cardiol 2007;120:e21-3.
2. Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine Baltimore 2004;83:315-34.
3. Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE. Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 2003;48:3542-3.
4. Moller DR. Treatment of sarcoidosis - from a basic science point of view. J Intern Med 2003;253:31-40.
5. Doty JD, Mazure JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005;127:1064-71.
6. Roberts SD, Wilkes DS, Burgett RA, Knox KS. Refractory sarcoidosis responding to infliximab. Chest 2003;124:2028-31.
7. Uthman I, Touma Z, Khoury M. Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol 2007;26:2001-3.
8. Walker PM, Marie PY, Danchin N, Bertrand A. Comparison of T1 estimation techniques in cardiac MRI. Magn Reson Imaging 1994;12:43-50.
9. Marie PY, Angioi M, Carteaux JP, et al. Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by black blood magnetic resonance imaging sequence. J Am Coll Cardiol 2001;37:825-31.
10. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate to severe heart failure: results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003;107:3133-40.